Effects of folic acid supplementation on hyperhomocysteinemia in CAPD patients : Effects on unsaturated fatty acids

Japanese Journal of Nephrology

Volumn 40, Issue 1, 1998, Pages 8-16

  Hirose, Satoru ^a   Kim, Songsu ^a   Matsuda, Akihiko ^a   Itakura, Yukihiro ^a   Matsumura, Osamu ^a   Tamura, Hirokazu ^a   Nagasawa, Ryuji ^a   Mitarai, Tetsuya ^a   Isoda, Kazuo ^a  

^a SAITAMA MEDICAL CENTER   (Japan)

Author keywords

CAPD; Folic acid; Hyperhomocysteinemia; Unsaturated fatty acid

Indexed keywords

ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; FOLIC ACID; HOMOCYSTEINE; SERINE; UNSATURATED FATTY ACID;

ADULT; AMINO ACID METABOLISM; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID SYNTHESIS; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; MALE; METHYLATION; RISK FACTOR; VASCULAR DISEASE;

ADMINISTRATION, ORAL; ADULT; AGED; FATTY ACIDS, UNSATURATED; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;

EID: 0031915838     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mudd SH, Finkelstein JD, Irrevere F, Laster L. Homocystinuria, an enzymatic defect. Science 1964 ; 143 : 1443-1445.
2. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In : Scriver C, Beaudet AL, Sly WS, Valle D, (eds) The metabolic basis of inherited disease 6th ed. Vol. 1 New York : McGraw-Hill, 1989 : 693-734.
3. Clarke R, Dary L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia : An independent risk factor for vascular disease. N Engl J Med 1991 ; 324 : 1149-1155.
4. Wilcken DEL, Gupta VJ. Sulphur containing amino acids in chronic renal failure with particular reference to homocysteine and cysteine-homocysteine mixed disulphide. Eur J Clin Invest 1979 ; 9 : 301-307.
5. Wilcken DEL, Gupta VJ, Reddy SG. Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis. Clin Sci 1980 ; 58 : 427-430.
6. Kang SS, Wong PWK, Bidani A, Milanez S. Plasma protein-bound homocyst (e) ine in patients requiring haemodialysis. Clin Sci 1983 ; 65 : 335-336.
7. Laidlaw SA, Smolin LA, Davidson WD, Kopple JD. Sulphur amino acids in maintenance hemodialysis patients. Kidney Int 1987 ; 32 Suppl. 22 : S191-S196.
8. Soria C, Chadefaux B, Coudé M, Gaillard O, Kamoun P. Concentrations of total homocysteine in plasma in chronic renal failure. Clin Chem 1990 ; 36 : 2137-2138.
9. Smolin LA, Laidlaw SA, Kopple JD : Altered plasma and protein-bound sulfur amino acids in patients undergoing maintenance hemodialysis. Am J Clin Nutr 1987 ; 45 : 737-743.
10. Bergström J, Alvestrand A, Fürst P, Lindholm B. Sulphur amino acid in plasma and muscle in patients with chronic renal failure : evidence for taurine depletion. J Intern Med 1989 ; 226 : 189-194.
11. Hultberg G, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993 ; 40 : 230-234.
12. Selhub J, Miller JW. The pathogenesis of homocysteinemia : interruption of the cocodinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992 ; 55 : 131-138.
13. Wilcken DEL, Dudman NPB, Tyrrell PA, Robertson MR. Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency : Possible implication for prevention of vascular disease. Metabolism 1988 ; 37 : 697-701.
14. Arnadottir M, Brattsröm L, Simonsen H, Thysell H, Hultberg B, Andersson A, Nilsson-Ehle P. The effect of high dose pyndoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993 ; 40 : 236-240.
15. Bostom AG, Shemin D, Lapane KL, Hume AL, Yoburn D, Nadeau MR, Bendich A, Selhub J, Rosenberg IH. High dose B-vitamin treatment of hyperhomocystememia in dialysis patients. Kidney Int 1996 ; 49 : 147-152
16. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease : Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997 ; 52 : 10-20.
17. Krumdieck CL, Eto I. Folates in tissues and cells. Support for a "two-tier"hypothesis of one carbon metabolism. In : Cooper BA, Whitehead MV (eds) Chemistry and Biology of Pteridines. Berlin : Walter de Gruyter, 1986 : 447-466.
18. Livant EJ, Tamura T, Johnston KE, Vaughn WH, Bergman SM, Forehand J, Walthaw J. Plasma folate conjugase activities and folate concentrations in patients receiving hemodialysis J Nutr Biochem 1994 ; 5 : 504-508.
19. Wall RT, Harlan JM, Harker LA, Striker GE. Homocysteine-induced endothelial cell injury in vitro : A model for the study of vascular injury. Thromb Res 1980 ; 18 : 113-121.
20. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986 ; 77 : 1370-1376.
21. Parthasarathy S. Oxidation of low density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochem Biophys Acta 1987 ; 917 : 337-340.
22. McCully KS. Chemical pathology of homocysteine I Atherogenesis Ann Clin Lab Sci 1993 ; 23 : 477-493.
23. Olszewski AJ, McCully KS. Homocysteine metabolism and the oxidative modification of protein and lipids. Free Radic Biol Med 1993 ; 14 : 683-693.